This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.
《Chemotherapy》是一本由KARGER出版商出版的專業醫學期刊，該刊創刊于1968年，刊期Bimonthly，該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 4區，小類學科：腫瘤學 4區；藥學 4區；在JCR（Journal Citation Reports）分區等級為Q3。該刊發文范圍涵蓋腫瘤學等領域，旨在及時、準確、全面地報道國內外腫瘤學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為3.549，平均審稿速度較慢,6-12周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 4區 | ONCOLOGY 腫瘤學 PHARMACOLOGY & PHARMACY 藥學 | 4區 4區 | 否 | 否 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q3 | ONCOLOGY | Q3 | 3.549 |
| PHARMACOLOGY & PHARMACY | Q3 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 3.549 | 49 | 3.53% | 73.53% | 未開放 | 較慢,6-12周 |
投稿咨詢
課題、SCI/EI/SSCI怎么寫？